[{"figure_path": "8B3sAX889P/tables/tables_6_1.jpg", "caption": "Table 1: Dataset Statistics", "description": "This table presents the statistics of the UK Biobank dataset used in the paper. It shows the number of unique patients, phenotypes, proteomics, and metabolomics, as well as the number of interactions between patients and phenotypes and the sparsity/missing rates for proteomics and metabolomics.", "section": "5.1 Experimental Setup"}, {"figure_path": "8B3sAX889P/tables/tables_7_1.jpg", "caption": "Table 2: Performance comparison for different models on varying dataset proportions.", "description": "This table presents the performance of the proposed MPI model and several baseline models on different proportions of the UK Biobank dataset (30%, 50%, 70%, 90%, and 100%).  The metrics used to evaluate performance are Hit@10, Hit@20, Hit@50, and MRR (Mean Reciprocal Rank). The table allows for a comparison of the models' ability to handle varying amounts of missing data and highlights the relative strengths and weaknesses of each model in different data scarcity scenarios.", "section": "5.2 Experimental Results"}, {"figure_path": "8B3sAX889P/tables/tables_7_2.jpg", "caption": "Table 3: Ablation study of variants comparison on 30% and 100% of the dataset.", "description": "This table presents the results of an ablation study comparing the proposed method (MPI) with several variants.  The variants systematically remove components of the MPI framework to evaluate their individual contributions.  Results are presented for both 30% and 100% of the dataset, showing the impact of each component on performance metrics including Hits@10, Hits@20, Hits@50, and MRR.", "section": "5.2 Experimental Results"}]